Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney

Kidney International

Volumn 50, Issue 6, 1996, Pages 2011-2019

  Xu, Yichun ^b   Hagege, Jacqueline ^b   Mougenot, Béatrice ^b   Sraer, Jean Daniel ^b   Rønne, Ebbe ^b   Rondeau, Eric ^a  

^a HÔPITAL TENON   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; RENAL ARTERY THROMBOSIS;

EID: 0029903407     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.523     Document Type: Article

References (36)

1. COLLEN D, LIJNEN HR: Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 78:3114-3124, 1991
2. DANØ K, ANDREASEN PA, GRØNDAHL-HANSEN J, KRISTENSEN P, NIELSEN LS, SKRIVER L: Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44:139-266, 1985
3. BLASI F, VASSALLI JD, DANO K: Urokinase-type plasminogen activator: Proenzyme, receptor and inhibitors. J Cell Biol 104:801-804, 1987
4. ELLIS V, BEHRENDT H, DANO K: Plasminogen activation by receptor-bound urokinase: A kinetic study with both cell-associated and isolated receptor. J Biol Chem 266:12752-12758, 1991
5. SAPPINO AP, HUARTE J, VASSALLI JD, BELIN D: Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney. J Clin Invest 87:962-970, 1991
6. LARSSON LI, SKRIVER L. NIELSEN LS: Distribution of urokinase-type plasminogen activator immunorcactivity in the mouse. J Cell Biol 98:984-903, 1984
7. KEETON M, EGUCHI Y, SAWDEY M, AHN C, LOSKUTOFF DJ: Cellular localization of type I plasminogen activator inhibitor messenger RNA and protein in murine renal tissue. Am J Pathol 142:59-70, 1993
8. ALMUS-JACOBS F, VARKI N, SAWDEY MS, LOSKUTOFF DJ: Endotoxin stimulates expression of the murine urokinase receptor gene in vivo. Am J Pathol 147:688-698, 1995
9. FENG L, TANG WW, LOSKUTOFF DJ, WILSON CB: Dysfunction of glomerular fibrinolysis in experimental antiglomerular basement membrane antibody glomerulonephritis. J Am Soc Nephrol 3:1753-1764, 1993
10. TOMOSUGI N, NAITO T, IKEDA K, YOKOYAMA H, KOHAYASHI K, KIDA H: The role of plasminogen activitor inhibitor (PAl) on anti-glomerular basement membrane antibody-mediated glomerular injury and it modulation by tumor necrosis factor (TNF). (abstract) Kidney Int 37:435, 1990
11. BARNES JL, MITCHELL RJ, TORRES ES: Expression of plasminogen activator inhibitor-1 (PAI-1) during cellular remodeling in proliferative glomerulonephritis in the rat. J Histochem Cytochem 43:859-905, 1995
12. ANGLES-CANO E, RONDEAU E, DELARUE F. HAGEGE J, SULTAN Y, SRAER JD: Identification and cellular localization of plasminogen activators from human glomeruli. Thromb Haemost 54:688-692, 1985
13. HASUI Y, SUZUMIYA J, SUMIYOSHI A, HASHIDA S, ISHIKAWA E: Distribution of plasminogen activators in human kidney and male genital organs using a highly sensitive enzyme immunoasay. Thromb Res 51:453-459, 1988
14. RONDEAU E, MOUGENOT B, LACAVE R, PERALDI MN, KRUITHOF EKO, SRAER JD: Plasminogen activator inhibitor 1 in renal fibrin deposits of human nephropathies. Clin Nephrol 33:55-60, 1990
15. WANG YM, THOMPSON EM, WHAWELL SA, FLEMING K: Expression and localization of plasminogen activator inhibitor 1 mRNA in transplant kidneys. J Pathol 169:445-450, 1993
16. REMUZZI G, RUGGENNENTI P: The hemolytic uremic syndrome. Kidney Int 47:2-19, 1995
17. KWAAN HC: Role of fibrinolysis in thrombotic thrombocytopenic purpura. Semin Hematol 24:101-109, 1987
18. BERGSTEIN JM, BANG NU: Plaminogen activator inhibitor-1 (PAI-1) is the circulating inhibitor of fibrinolysis (PAI-HUS) in the hemolytic-uremic syndrome (HUS). (abstract) Kidney Int 37:254, 1990
19. LOSKUTOFF DJ, VAN MOURIK JA, ERICKSON LA, LAWRANCE D: Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells. Proc Natl Acad Sci USA 80:2956-2960, 1983
20. KRUITHOF EKO, TRAN-THANG C, BACHMANN F: Studies on the release of a plasminogen activator inhibitor by human platelets. Thromb Haemost 55:201-205, 1986
21. RØNNE E, BEHRENDT N, ELLIS V, PLOUG M, DANØ K, HØYER-HANSEN G: Cell-induced potentiation of the plasminogen activation system is abolished by monoclonal antibody that recognizes the NH2-terminal domain of urokinase receptor. FEBS Lett 288:233-236, 1991
22. PYKE C, GRAEM N, RALFKIAER E, RØNNE E, HØYER-HANSEN G. BRÜNNER N, DANØ K: Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res 53:1911-1915, 1993
23. HAGÈGE J, DELARUE F, PERALDI MN, SRAEK JD, RONDEAU E: Heparin selectively inhibits synthesis of tissue-type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells. Lab Invest 71:828-837, 1994
24. NGUYEN G, LI XM, PERALDI MN, ZACHARIAS U, HAGÈGE J. RONDEAU E, SRAER JD: Receptor binding and degradation of urokinase-type plasminogen activator by human mesangial cells. Kidney Int 46:208-215, 1994
25. CORDELL JL, FALINI B, ERBER WN, GHOSH AK, ABDULAZIZ Z, MACDONALD S, PULFORD KAF, STEIN H, MASON DY: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219-229, 1984
26. GUESDON JL, TERNYNCK T, AVRAMEAS S: The use of avidin-biolin interaction in immunoenzymatic techniques. J Histochem Cytochem 27:1131-1139, 1979
27. WOOD GS, WARNKE R: Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems. J Histochem Cytochem 29:1196-1204, 1981
28. FEINBERG AP, VOGELSTEIN B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13, 1983
29. BIANCHI E, COHEN RL, THOR AT, TODD RF III, MIZUKAMI IF, LAWRENCE DA, LJUNG BM, SHUMAN MA, SMITH HS: The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res 54:861-866, 1994
30. PYKE C, KRISTENSHN P, RALFKIAER E, GRØNDAHL-HANSEN J, ERIKSEN J, BLASI F, DANØ K: Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am J Pathol 138:1059-1067, 1991
31. PYKE C, RALFKIAER E, RØNNE E, HØYER-HANSEN G, KIRKEBY L, DANØ K: Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancer. Histopathology 24:131-138, 1994
32. OLSON D, PÖLLÄNEN J, HOYER-HANSEN G, RONNE E, SAKAGUCHI K, WUN TC, APPELLA E, DANO K, BLASI F: Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor. J Biol Chem 267:9129-9133, 1992
33. NUSRAT AR, CHAPMAN HA JR: An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines. J Clin Invest 87:1091-1097, 1991
34. RABBANI SA, MAZAR AP, BERNIER SM, HAQ M, BOLIVAR I, HENKIN J, GOLTZMAN D: Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J Biol Chem 267:14151-14156, 1992
35. ANICHINI E, FIBBI G, PUCCI M, CALDINI R, CHEVANNE M, DEL ROSSO M: Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase eceptor. Exp Cell Res 213:438-448, 1994
36. NYKJAER A, PETERSEN CM, MØLLER B: Purified alpha2-macroglobulin receptor/LDL receptor-related protein binds urokinase plasminogen activator inhibitor type-1 complex. J Biol Chem 267:14543-14546, 1992